Nova Eye Medical (ASX: EYE) — Perfil da empresa, notícias e dados financeiros
Nova Eye Medical is an Australian medical device company focused on glaucoma treatment options and advanced technologies.
Nova Eye Medical
Nova Eye Medical is a medical technology company specializing in the design, development, and commercialization of ophthalmic devices and surgical technologies for the treatment of glaucoma and retinal disease. Headquartered in Australia with commercial operations across North America, Europe, and Asia-Pacific, the company develops interventional glaucoma products designed to restore natural fluid drainage within the eye. Its commercial portfolio includes microcatheters for canaloplasty procedures, glaucoma drainage implants for advanced cases, and proprietary viscoelastic delivery tools used by ophthalmic surgeons in clinical settings worldwide.
Resumo
Operações
Produtos e/ou serviços de Nova Eye Medical
- Canaloplasty Microcatheters: Handheld illuminated microcatheters with integrated delivery systems designed for catheterization and viscodilation of Schlemm canal, enabling minimally invasive glaucoma surgery across outpatient surgical centers and hospital operating rooms globally.
- Glaucoma Drainage Implants: Polypropylene glaucoma drainage devices featuring a thin four-millimeter plate designed to sit against the sclera, providing intraocular pressure reduction in severe and refractory open-angle glaucoma cases across international healthcare markets.
- Viscoelastic Delivery Systems: Specialized delivery handpieces and fluid manipulation technologies that transform cohesive viscoelastic into lower-viscosity fluid during canaloplasty to facilitate fluid penetration throughout the eye's conventional outflow pathways during surgery.
- Goniotomy Instruments: Ophthalmic surgical tools engineered for trabecular meshwork disruption, tissue cutting, and fluid aspiration during ab interno surgical glaucoma procedures performed by ophthalmic specialists in hospital operating rooms.
- Retinal Laser Therapies: Nanosecond pulse laser systems designed for non-thermal rejuvenation of the retinal pigment epithelium, targeting early-stage age-related macular degeneration and diabetic macular edema across clinical evaluation sites.
- Surgical Education Programs: Medical education platforms, clinical webinars, and hands-on wet lab training sessions provided to ophthalmic surgeons and glaucoma specialists across primary operating markets in North America, Europe, and Asia-Pacific.
equipe executiva do Nova Eye Medical
- Victor PrevinFounder & Chairman
- Thomas H. SpurlingMD & Executive Director
- Michael SouthardExecutive Director
- Kimberley MenziesChief Financial Officer
- Mark FlynnInvestor Relations
- Kate HuntChief Commercial Officer
- Joe BankovichPresident of Global Sales
- Joaquin V. WolffPresident of Ellex iTrack
- Simon Jeremy Newton GrayCompany Secretary
- Jordan PossinghamFinancial Controller
Últimas notícias sobre a Nova Eye Medical
Histórico de dividendos
Dividendos por ação pagos pela Nova Eye Medical, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2021 | — | — | A$0.4138 | A$0.8619 |
| FY2003 | — | — | — | A$0.0225 |
Principais indicadores financeiros
Resultados divulgados pela Nova Eye Medical, em AUD.
- Cap. de mercado
- 42,7 mi
- Receita (TTM)
- 34,9 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.0
- Dividend yield
- —
- Margem de lucro
- -12.4%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 34,9 mi | -4,4 mi | -4,3 mi | |
| 29,3 mi | -11,2 mi | -9,1 mi | |
| 23,3 mi | -9 mi | -8,8 mi | |
| 17 mi | -11,8 mi | -15,3 mi |